Psychiatry and Neurology, Neurology · Summit, NJ
NPI
1750445680
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
99 Beauvoir Ave, Overlook Medical Center --Dept of Neurology
Summit, NJ, 07902
Phone (908) 522-6144
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
16,771 services
Medicare patients, 2024
182
Average age 75
Drug cost, 2024
$341K
721 prescriptions
Company payments, 2025
$37K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marcie L Rabin was code J0585 (injection, onabotulinumtoxina, 1 unit), 8,553 times for 25 patients. In total Marcie L Rabin billed 16,771 services in 27 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 8,553 | 25 | $4.81 | $41K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 7,289 | 17 | $4.08 | $30K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 153 | 73 | $27.21 | $4,162 |
| 99215 Office E&M - Established | Office | 152 | 95 | $149.51 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 124 | 88 | $13.97 | $1,733 |
| 99214 Office E&M - Established | Office | 63 | 43 | $106.33 | $6,699 |
| 99205 Office E&M - New | Office | 58 | 58 | $173.56 | $10K |
| 64616 Musculoskeletal | Office | 54 | 21 | $141.00 | $7,614 |
| 76942 Ultrasound - Nonspecific | Office | 39 | 22 | $48.29 | $1,883 |
| 64646 Musculoskeletal | Office | 37 | 17 | $76.34 | $2,824 |
| 64612 Musculoskeletal | Office | 37 | 12 | $164.75 | $6,096 |
| 95874 Musculoskeletal | Office | 35 | 15 | $64.00 | $2,240 |
| 64644 Musculoskeletal | Office | 34 | 16 | $138.31 | $4,703 |
| 64643 Musculoskeletal | Office | 27 | 11 | $81.33 | $2,196 |
| 99213 Office E&M - Established | Office | 18 | 12 | $79.33 | $1,428 |
By year: 2022 $139K for 22,143 services; 2023 $203K for 28,435 services; 2024 $153K for 16,771 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marcie L Rabin prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 205 prescriptions and refills. In total Marcie L Rabin wrote 721 Medicare prescriptions that cost $341K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 205 | 522 | 84 | $10K |
| Amantadine Amantadine Hcl | 65 | 170 | 29 | $4,966 |
| Botox Onabotulinumtoxina | 45 | 120 | 22 | $103K |
| Selegiline Hcl Generic | 41 | 118 | 22 | $3,342 |
| Gabapentin Generic | 35 | 97 | 14 | $1,137 |
| Clonazepam Generic | 35 | 66 | 13 | $619 |
| Propranolol Hcl Generic | 24 | 67 | 11 | $861 |
| Rasagiline Mesylate Generic | 24 | 66 | 13 | $6,459 |
| Primidone Generic | 20 | 46 | Under 11 | $615 |
| Xeomin Incobotulinumtoxina | 18 | 50 | 11 | $23K |
| Baclofen Generic | 18 | 32 | Under 11 | $249 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 17 | 43 | Under 11 | $408 |
| Rytary Carbidopa/Levodopa | 16 | 36 | Under 11 | $20K |
| Topiramate Generic | 13 | 36 | Under 11 | $149 |
| Austedo Deutetrabenazine | 13 | 13 | Under 11 | $92K |
Brand drugs: 121 claims; generic drugs: 600 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marcie L Rabin $37K ($37K in general payments such as food, travel and fees) from 12 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $36K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.